Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells

Human Immunology

Volumn 61, Issue 8, 2000, Pages 721-728

  Luque, Isabel ^a   Reyburn, Hugh ^a   Strominger, Jack L ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

CD80; CD86; Cytotoxicity; NK cells; Triggering

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TARGET CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELL LINE; CELL LINE, TRANSFORMED; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION; HUMANS; KILLER CELLS, NATURAL; MEMBRANE GLYCOPROTEINS; MICE;

EID: 0033817211     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00136-1     Document Type: Article

References (45)

1. Killer cells: A functional comparison between natural, immune T-cell and antibody-dependent in vitro systems
2. In search of the 'missing self': MHC molecules and NK cell recognition
3. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1 and NK2 specific natural killer cells
4. Multiple receptors for HLA-G on human natural killer cells
5. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
6. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer
7. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule
8. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors
9. NK cell receptors
10. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLclass I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
11. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer
12. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
13. Kinetics and peptide dependency of the binding of the inhibitory receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
14. Transduction of cytotoxic signals in natural killer cells: A general model of fine tuning between activatory and inhibitory pathways in lymphocytes
15. Reconstitued killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs
16. Signal transduction during natural killer cell activation: Inside the mind of a killer
17. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity
18. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
19. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis
20. ICAM-2 redistributed by ezrin as a target for killer cells
21. A new mechanism of NK cell cytotoxicity activation: The CD40-CD40 ligand interaction
22. Expression of B7-B1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity
23. B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma
24. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)
25. Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells
26. Triggering of murine NK cells by CD40 and CD86 (B7.2)
27. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes
28. Comparative studies of human FcRIII-positive and negative natural killer cells
29. Absence of B7.1-CD28/CTLA-4-mediated co-stimulation in human NK cells
30. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL
31. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules
32. TCGF (IL-2)-receptor inducing factor(s). I. Regulation of IL-2 receptor on a natural killer-like cell line (YT cells)
33. Characterization of a human cell line (NK-92) with phenotypical and functiuonal characteristics of activated natural killer cells
34. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression
35. Natural killer cells: From no receptors to too many
36. CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase and protein kinase C
37. Expression of a variant of CD28 on a subpopulation of human NK cells: Implications for B-7 mediated stimulation of NK cells
38. NKRP-1A is a target specific receptor that activates natural killer cell cytotosicity
39. Independent modes of natural killing distinguished in mice lacking lag 3
40. Functional rafts in cell membranes
41. Structure and dimerization of a soluble form of B7-1
42. Cutting edge: Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor
43. + natural killer cells requires the expression of an autosomic recessive gene on target cells
44. Regulation of self-tolerance by CD80/CD86 interactions
45. IL-12 Up-regulates CD40 ligand (CD154) expression on human T cells